These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2004-004693-87 Randomized study on therapy of Strongyloides stercoralis invasion: ivermectine VS thiabendazole bad-data
Completed, but no date 2006-002424-42 Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal C... bad-data
Completed, but no date 2006-005315-10 Evaluation of safety and efficacy on visual acuity outcome of intravitreal somministration of Bevacizumab in patients with diabetic retinopathy bad-data
Ongoing 2011-001724-38 Use of 68-Ga-DOTANOC for the assessment of human neuroendocrine tumors by imaging with Positron Emission Tomography (PET) Impiego del 68-Ga-DOTANOC nella diagnostica per immagini mediante Tomografi... not-yet-due
Other 2011-002784-24 Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple versus Single Dose of Ivermectin for the Treatment of Strongyloides not-yet-due
Ongoing 2018-003652-21 Interventional two arms open-label study for evaluating the diagnostic performance of PET PSMA in patients affected by biochemical recurrent prostate cancer. Studio interventistico a due braccia, i... not-yet-due
Reported results Terminated 2020-002283-32 Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19 Studio clinico randomizzato, in doppio cieco, multic... 2021-06-29 due-trials